|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-9-5
|
|
pubmed:abstractText |
To evaluate the relationship between the severity of secondary hyperparathyroidism (SHPT) - defined in terms of baseline plasma intact parathyroid hormone (iPTH) level - and the magnitude of response to cinacalcet.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0301-0430
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
76
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
233-43
|
|
pubmed:meshHeading |
pubmed-meshheading:21888861-Adult,
pubmed-meshheading:21888861-Aged,
pubmed-meshheading:21888861-Aged, 80 and over,
pubmed-meshheading:21888861-Calcimimetic Agents,
pubmed-meshheading:21888861-Calcium,
pubmed-meshheading:21888861-Female,
pubmed-meshheading:21888861-Humans,
pubmed-meshheading:21888861-Hyperparathyroidism, Secondary,
pubmed-meshheading:21888861-Male,
pubmed-meshheading:21888861-Middle Aged,
pubmed-meshheading:21888861-Naphthalenes,
pubmed-meshheading:21888861-Parathyroid Hormone,
pubmed-meshheading:21888861-Phosphates,
pubmed-meshheading:21888861-Randomized Controlled Trials as Topic,
pubmed-meshheading:21888861-Young Adult
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Cinacalcet reduces plasma intact parathyroid hormone, serum phosphate and calcium levels in patients with secondary hyperparathyroidism irrespective of its severity.
|
|
pubmed:affiliation |
School of Medicine, Porto University, Porto, Portugal. jmmdfrazao@netcabo.pt
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
